(Q28378181)

English

Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine

scientific article published in December 1999

In more languages

Statements

scholarly article

0 references

Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine (English)

0 references

0 references

echocardiography

1 reference

based on heuristic

inferred from title

author name string

M K Kancherla

1

0 references

H I Salti

2

0 references

T A Mulderink

3

0 references

M Parker

4

0 references

R O Bonow

5

0 references

D J Mehlman

6

0 references

language of work or name

0 references

publication date

1 December 1999

0 references

American Journal of Cardiology

0 references

84

0 references

11

0 references

1335-8

0 references

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Morphology of the human mitral valve. II. The value leaflets

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Color Doppler evaluation of valvular regurgitation in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900567-6

7 January 2021

Identifiers

10.1016/S0002-9149(99)00567-6

0 references

release_7cvvrdcfffgjvlvthbtulxcusi

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28378181&oldid=1371373641"